Arkadios Wealth Advisors Aim Immuno Tech Inc. Transaction History

Arkadios Wealth Advisors

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 03, 2022	SELL	$0.92 - $1.96 $19,869 - $42,330	-21,597 Closed	0 $0
Q3 2021 Oct 19, 2021	BUY	$1.91 - $2.17 $41,250 - $46,865	21,597 New	21,597 $43,000
Q1 2021 Apr 26, 2021	SELL	$1.88 - $2.82 $37,600 - $56,400	-20,000 Closed	0 $0
Q3 2020 Nov 10, 2020	BUY	$1.77 - $3.88 $35,400 - $77,600	20,000 New	20,000 $45.4 Million

9.01M

Ticker AIM
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,049,300
Market Cap $11.1M
Description
AIM ImmunoTech Inc., an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States. The company's products include Ampligen, a drug of macromolecular ribonucleic acid molecules for the treatment of chronic fatigue syndrome...

Get notified when there are updates to the investment portfolio of Arkadios Wealth Advisors, based on Form 13F filings with the SEC.

Stay updated on Arkadios Wealth Advisors with notifications on news.